Advanced Search

Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > The Journal of Cardiovascular Surgery 2000 August;41(4) > The Journal of Cardiovascular Surgery 2000 August;41(4):637-40

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUETHE JOURNAL OF CARDIOVASCULAR SURGERY

A Journal on Cardiac, Vascular and Thoracic Surgery

Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,632

Frequency: Bi-Monthly

ISSN 0021-9509

Online ISSN 1827-191X

 

The Journal of Cardiovascular Surgery 2000 August;41(4):637-40

THORACIC PAPERS 

    ORIGINAL ARTICLES

Morbidity and survival after bronchoplastic surgery for non-small-cell lung cancer

Schinkel C., Mueller C., Reinmiedl J., Fuerst H.

From the Depart­ment of Sur­gery Klin­ikum Gross­hadern Ludwig-Max­i­mil­ians Uni­ver­sity, ­Munich, Ger­many

Back­ground. Bron­cho­plastic pro­ce­dures are an ­accepted sur­gical ­approach in ­patients ­with resect­able non-­small-­cell ­lung ­cancer (­NSCLC) to ­avoid pneu­mo­nec­tomy. Post­op­er­a­tive com­pli­ca­tions asso­ciated ­with the bron­chial anas­tom­osis and ­local recur­rence of the ­tumor ­have to be con­sid­ered. Experi­mental ­design and set­ting: Ret­ro­spec­tive anal­ysis of the clin­ical ­courses and ­follow-up of 1610 con­sec­u­tive ­patients who ­received sur­gical resec­tion for ­NSCLC at the Depart­ment of Sur­gery, Klin­ikum Gross­hadern, Uni­ver­sity of ­Munich, Ger­many. ­Among ­them ­there ­were 134 (8.3%) bron­cho­plastic resec­tions.
­Methods. Mor­bidity, mor­tality, and sur­vival ­rate ­were inves­ti­gated in ­these ­patients to ­verify the ­safety of ­this tech­nique.
­Results. ­From all 134 bron­cho­plastic resec­tions, 105 lobec­to­mies, 22 bilo­bec­to­mies, and 7 pneu­mo­nec­to­mies ­were per­formed. Ate­lec­tasis was ­observed in 6.0% (versus con­ven­tional pro­ce­dures: 3.7%; p: n.s.), ­whereas anas­to­motic dehis­cence ­occurred in 3.0%. In-hos­pital mor­tality ­amounted to 3.7% (­versus 5.3%; p: n.s.). The ­stage depen­dent 5-­year sur­vival in R0-­resected ­patients was com­par­able in ­both ­groups.
Con­clu­sions. Our ­results dem­on­strate ­that bron­cho­plastic pro­ce­dures rep­re­sent a ­safe ther­a­peutic ­option in the oper­a­tive treat­ment of non-­small-­cell ­lung ­cancer ­that ­should be con­sid­ered in all ­patients ­with cen­tral ­tumor ­growth.

language: English


FULL TEXT  REPRINTS

top of page